-
Thomas Weisel Partners More Than Double InterMune (ITMN) Price Target To $55
Wednesday, March 10, 2010 - 9:15amThomas Weisel Partners analyst Stephen Willey maintained his Overweight rating for shares of InterMune, Inc. (Nasdaq: ITMN) and raised the price target from $26 to $55. The day before, a panel at the Food and Drug Administration recommended InterMune's pirfenidone for the treatment of idiopathic...
Read More >> -
Wells Fargo Securities Rates InterMune (ITMN) Market Perform
Monday, March 8, 2010 - 12:37pmWells Fargo Securities analysts Aaron Reames and Matthew J. Andrews rated shares of InterMune, Inc. (Nasdaq: ITMN) Market Perform. The analysts questioned whether or not the FDA would accept InterMune's use of Forced Vital Capacity, as opposed to Overall Survival as the appropriate endpoint for the...
Read More >>
pirfenidone
From Benzinga's Newsdesk
- 07:03 AM Rainmaker Signs Three-Year Agreement with Aruba Networks
- 07:03 AM The Wet Seal, Inc. Announces May Comparable Store Sales Declined 8.8%
- 07:02 AM The Buckle, Inc. Reports May 2012 Net Sales
- 07:02 AM Cato May Same-Store Sales Up 3%
- 07:01 AM Limited Brands May Sales up 6%
- 7:01 AM Ciena Reports Q2 EPS $0.04 vs $-0.02 Est; Revenues $477.6M vs $447.37M Est
- 07:01 AM Omeros Announces Initiation of Planned Pharmacokinetic Substudy in OMS302 Phase 3 Clinical Program
- 07:00 AM Cracker Barrel Announces Two New Directors Appointed to Board
- 07:00 AM Cracker Barrel Announces Two New Directors Appointed to Board
- 6:57 AM Morgan Stanley Initiates Coverage on Sandisk at Overweight, Announces PT of $45
- 6:56 AM Morgan Stanley Initiates Coverage on Intel at Underweight, Announces PT of $26
- 6:56 AM Bank of America Maintains Protective Life at Underperform, Raises PO from $29 to $31
- 06:55 AM ENGlobal Finalizes Credit Facility with PNC
- 6:55 AM Guggenheim Maintains Dollar General at Buy, Raises PT from $54 to $57
- 6:55 AM JP Morgan Maintains The Fresh Market at Overweight, Raises PT from $55 to $61
Brain Trust
- The Buckle, Inc. Reports May 2012 Net Sales
- Cato May Same-Store Sales Up 3%
- Limited Brands May Sales up 6%
- Omeros Announces Initiation of Planned Pharmacokinetic Substudy in OMS302 Phase 3 Clinical Program
- Cracker Barrel Announces Two New Directors Appointed to Board
- Cracker Barrel Announces Two New Directors Appointed to Board
- ENGlobal Finalizes Credit Facility with PNC
- Graham Corporation Awarded $5 Million in Orders for Nuclear Energy Facilities and Oil Refinery in China
- UPDATE: Imperial Capital Initiates Orbital Sciences Corporation with Outperform, $19 PT on Lower R&D, Antares Rocket
- UPDATE: Imperial Capital Raises PT to $41 on Spirit Airlines on Positive Impact From Fuel Prices
- Is Facebook Secretly Cloning the iPhone 5?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Was IBM Smart to Ban Siri?
- James Altucher Article Sends Neonode Soaring
- 5 Small-Cap Short Ideas
- Why Einhorn Is Wrong About Apple
- Facebook and Apple Together at Last?
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- Social Media Chatter on Dell Around Its Earnings Report
